Drugs / HF1020
last change Oct 2011 re-read 3 minutes ago

HF1020

Investigated by
Trident Pharmaceuticals Inc

Trials 1

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01425450 Jul → Oct 2011 — Trident Pharmaceuticals Inc Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HF1020 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01425450 ↗